5-fluoropyrimidine has been researched along with Recrudescence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrada, E; Aparicio, J; Burgos, E; Calatrava, A; Cejas, P; Custodio, A; Díaz-López, E; Feliu, J; Gallego-Plazas, J; Madero, R; Maurel, J; Moreno-Rubio, J; Ramos, D; Rodríguez-Salas, N; Sánchez, A; Yaya, R | 1 |
| Calin, GA; Dubois, RN; Ellis, LM; Eng, C; Gu, J; Hawk, ET; Hildebrandt, MA; Huang, M; Lin, J; Lin, M; Wang, D; Wu, X | 1 |
2 other study(ies) available for 5-fluoropyrimidine and Recrudescence
| Article | Year |
|---|---|
Pharmacogenetic predictors of outcome in patients with stage II and III colon cancer treated with oxaliplatin and fluoropyrimidine-based adjuvant chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; DNA Repair; E-Selectin; Genotype; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Organoplatinum Compounds; Oxaliplatin; Pharmacogenetics; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Pyrimidines; Recurrence; Regression Analysis; Retrospective Studies; Treatment Outcome; Young Adult | 2014 |
Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients.
Topics: Adenocarcinoma; Adult; Aged; Colorectal Neoplasms; Disease-Free Survival; Female; Genotype; Humans; Male; MicroRNAs; Middle Aged; Neoplasm Staging; Polymorphism, Single Nucleotide; Prognosis; Pyrimidines; Recurrence; Treatment Outcome | 2012 |